Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by OLD National Bancorp IN

OLD National Bancorp IN reduced its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 17.6% in the 4th quarter, HoldingsChannel.com reports. The fund owned 50,139 shares of the pharmacy operator’s stock after selling 10,681 shares during the quarter. OLD National Bancorp IN’s holdings in Walgreens Boots Alliance were worth $1,309,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. CWM LLC lifted its holdings in Walgreens Boots Alliance by 53.2% in the 3rd quarter. CWM LLC now owns 33,393 shares of the pharmacy operator’s stock worth $743,000 after buying an additional 11,602 shares in the last quarter. IFP Advisors Inc increased its stake in Walgreens Boots Alliance by 15.3% in the 3rd quarter. IFP Advisors Inc now owns 20,975 shares of the pharmacy operator’s stock valued at $466,000 after buying an additional 2,784 shares during the period. Global Retirement Partners LLC increased its stake in Walgreens Boots Alliance by 16.3% in the 3rd quarter. Global Retirement Partners LLC now owns 12,890 shares of the pharmacy operator’s stock valued at $287,000 after buying an additional 1,804 shares during the period. HB Wealth Management LLC increased its stake in Walgreens Boots Alliance by 48.5% in the 3rd quarter. HB Wealth Management LLC now owns 11,019 shares of the pharmacy operator’s stock valued at $245,000 after buying an additional 3,598 shares during the period. Finally, SG Americas Securities LLC increased its stake in Walgreens Boots Alliance by 101.7% in the 3rd quarter. SG Americas Securities LLC now owns 152,056 shares of the pharmacy operator’s stock valued at $3,382,000 after buying an additional 76,673 shares during the period. 58.59% of the stock is owned by institutional investors and hedge funds.

Walgreens Boots Alliance Stock Down 0.9 %

Walgreens Boots Alliance stock opened at $18.05 on Wednesday. The stock has a market capitalization of $15.57 billion, a PE ratio of -2.58, a price-to-earnings-growth ratio of 1.13 and a beta of 0.73. Walgreens Boots Alliance, Inc. has a twelve month low of $17.51 and a twelve month high of $35.54. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 0.50. The company has a 50 day moving average of $20.26 and a 200-day moving average of $21.86.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, topping the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The business had revenue of $37.05 billion during the quarter, compared to analysts’ expectations of $35.86 billion. During the same quarter in the prior year, the company posted $1.16 earnings per share. The firm’s revenue was up 6.3% on a year-over-year basis. On average, equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Valerie B. Jarrett purchased 4,456 shares of the company’s stock in a transaction on Monday, January 29th. The shares were purchased at an average cost of $22.44 per share, with a total value of $99,992.64. Following the completion of the transaction, the director now owns 4,456 shares of the company’s stock, valued at approximately $99,992.64. The transaction was disclosed in a filing with the SEC, which is available through this link. In other news, CFO Manmohan Mahajan acquired 6,000 shares of Walgreens Boots Alliance stock in a transaction on Tuesday, April 2nd. The shares were purchased at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the purchase, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Valerie B. Jarrett acquired 4,456 shares of the company’s stock in a transaction that occurred on Monday, January 29th. The stock was acquired at an average price of $22.44 per share, with a total value of $99,992.64. Following the acquisition, the director now owns 4,456 shares in the company, valued at $99,992.64. The disclosure for this purchase can be found here. Over the last three months, insiders have bought 13,456 shares of company stock valued at $270,423. 17.40% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research firms have weighed in on WBA. Barclays initiated coverage on shares of Walgreens Boots Alliance in a research note on Wednesday, January 3rd. They issued an “underweight” rating and a $21.00 price objective on the stock. UBS Group decreased their price objective on shares of Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating for the company in a report on Wednesday, April 3rd. SVB Leerink decreased their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating on the stock in a research report on Monday, March 18th. TD Cowen reduced their price target on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating on the stock in a research report on Wednesday, April 3rd. Finally, Bank of America reduced their price target on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating on the stock in a research report on Tuesday, March 26th. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $24.36.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.